- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
10
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
10 companies
Lee's Pharmaceutical Holdings
Market Cap: HK$942.1m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.60
7D
10.3%
1Y
41.6%
TOT BIOPHARM International
Market Cap: HK$1.5b
An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
1875
HK$1.91
7D
3.2%
1Y
-10.7%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.23
7D
1.4%
1Y
71.5%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$2.0b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.35
7D
7.1%
1Y
13.4%
Jacobson Pharma
Market Cap: HK$3.3b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.65
7D
-2.9%
1Y
179.7%
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$3.10
7D
-1.3%
1Y
226.3%
Essex Bio-Technology
Market Cap: HK$3.0b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.28
7D
16.3%
1Y
120.0%
Alphamab Oncology
Market Cap: HK$8.3b
A clinical stage biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology biologics.
9966
HK$8.65
7D
26.1%
1Y
287.9%
Consun Pharmaceutical Group
Market Cap: HK$10.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$12.38
7D
7.7%
1Y
113.8%
China Shineway Pharmaceutical Group
Market Cap: HK$6.3b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.30
7D
1.5%
1Y
4.0%